This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Epidemic Increases In Melanoma Rates Three Of Four Americans Surveyed Have Never Had Skin Cancer Examination

Stocks in this article: MELA

"Annual skin cancer screenings are critically important because they can catch skin cancer, including melanoma, in its earliest, most curable stage," said Darrell Rigel, MD, Clinical Professor of Dermatology, New York University. "I advise my patients to monitor their moles on an ongoing basis and to come into the office for a professional full-body skin cancer screening at least once a year."

Annual ExamsThe survey findings show that the majority of American adults (86%) have had a physical exam by a physician but that Americans are less likely to have had a skin cancer screening by a dermatologist. Older adults are significantly more likely to have had a skin cancer screening, compared to their younger counterparts (40% of those ages 55+ vs. 16% of those ages 18-54), even though melanoma is one of the more common cancers in people younger than 30. 1

Survey findings also show that 26% of American women have had a skin cancer screening by a dermatologist, compared to 23% of men. Adults in the Northeast (28%) and South (25%) are significantly more likely to have had a skin cancer screening than those who live in the Midwest (19%).

Self-ExamsThe survey found that more than half (51%) of Americans do not regularly conduct monthly self-exams including breast, testicular and mole checks. Women are more likely to perform monthly mole self-checks than men (26% and 19%, respectively). Interestingly, a larger percentage of adults who have had a skin cancer screening by a dermatologist perform monthly mole self-checks (39%).

Cancer RiskEven with advancements in sun protection technology and education on the importance of sunscreen in protecting against the risks of skin cancer, the survey shows that over two in five (43%) of U.S. adults say skin cancer "is not something they worry about." Younger men are significantly more likely to say they do not believe they are at risk for skin cancer than their older counterparts (45% of men ages 18-44, 33% of men ages 55+). 37% of Americans also agree that melanoma is treatable, no matter "what stage it is caught."

"We continue to push the need for self-exams at home and screenings by board-certified dermatologists, as the combination of both exams gives a higher likelihood of identifying skin cancer at earlier stages," said Laura K. Ferris, MD, PhD, Assistant Professor of Dermatology, University of Pittsburgh Medical Center. "We know that some consumers may look at smartphone applications for guidance, but my recent study shows that these apps are not reliable tools, with three out of four applications incorrectly classifying 30% or more of melanomas as unconcerning. 2 There is simply no substitute for seeing a dermatologist for a full skin cancer screening."

"During our skin cancer screenings, we now have the advantage of using MelaFind® on unusual moles which helps us learn about the characteristics of a mole, said Dr. Rigel. "In turn, we're becoming better diagnosticians and are better able to identify melanoma in its most curable stages."

2 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,959.44 +154.64 0.87%
S&P 500 2,078.54 +7.89 0.38%
NASDAQ 4,781.4240 +16.0440 0.34%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs